Researchers' Profiles

Suzette Glasner-Edwards, Ph.D.

Suzette Glasner-Edwards, Ph.D.

Principal Investigator

Suzette Glasner-Edwards, Ph.D. is a licensed clinical psychologist and a Principal Investigator at UCLA Integrated Substance Abuse Programs. She earned her B.A. in psychology from UCLA and her Ph.D. in psychology at the University of Minnesota. Subsequently she completed her post-doctoral training at UCSD and the San Diego VA in the study and practice of psychotherapy for addictions. Dr. Glasner-Edwards has extensive clinical and research background in the use of cognitive-behavioral, motivational, and mindfulness-based interventions for adults who have substance use disorders with and without concurrent mental illness. Dr. Glasner-Edwards teaches these therapy techniques to psychiatry residents and psychologists in post-doctoral training at UCLA. A recipient of a career development award from NIDA, Dr. Glasner-Edwards’ current research focuses on developing technology-assisted psychosocial interventions and evaluating treatment outcomes for drug abusing adults with co-occuring psychiatric illness (with a particular focus on depression). She has also conducted research on pharmacological treatments for stimulant users with depression. Her interests include psychological and pharmacological intervention development and outcome evaluation for substance abusers with co-occurring psychiatric and medical conditions (e.g., HIV), the clinical course of psychiatric illness in individuals with alcohol and/or drug use disorders, mechanisms of action or “key ingredients” of psychotherapy and risk factors for mental illness among substance abusers.

  • Undergraduate: University of California at Los Angeles, B.A., Psychology, 1998
  • Graduate School: University of Minnesota, Ph.D., 2002
  • Internship: University of California at San Diego, Psychiatry and VA San Diego Healthcare System, Alcohol and Drug Treatment Program, 2002-2003
  • Post-Doctoral Fellowship: VA San Diego Healthcare System, 2003-2004
  • License: California Board of Psychology, PSY 19704, 2004
  • Addiction
  • Affective Disorders
  • Comorbidity
  1. Glasner-Edwards, S., Mooney, L.M., Ang, A., Hillhouse, M., & Rawson, R.A. (in press). Does post-traumatic stress disorder affect post-treatment methamphetamine use? Journal of Dual Diagnosis.
  2. Glasner-Edwards, S. (2011). Motivational interventions for substance abusers with psychiatric illness. In: W.M. Cox & E. Klinger (Eds.), Handbook of Motivational Counseling: Second Edition. England: Wiley & Sons, p.329-347.
  3. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2011). Bulimia nervosa among methamphetamine dependent adults: association with outcomes 3 years after treatment. Eating Disorders: The Journal of Treatment and Prevention, 19(3): 259-269.
  4. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2010).  Anxiety disorders among methamphetamine dependent adults: association with posttreatment outcomes. American Journal on Addictions, 19(5):385-390.
  5. Glasner-Edwards, S., & Rawson, R.A. (2010). Evidence-based practices in addiction treatment: review and recommendations for public policy. Health Policy, 97:93-104.
  6. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2010). Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug & Alcohol Review, 29:12-20.
  7. Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, W., Colescott, P., Ling, W., & Rawson, R.A. (2009). Health conditions in methamphetamine-dependent adults 3 years after treatment. Journal of Addiction Medicine, 3(3): 155-163.
  8. Glasner-Edwards, S., Marinelli-Casey, P., Gonzales, R., Hillhouse, M., et al. (2009). Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. Journal of Nervous & Mental Disease, 197: 225-231.
  9. Gavriel, M., Glasner-Edwards, S., & Sackler, H. (2008). Response: Innovations and implementation. Addiction Science & Clinical Practice, 4(2), 47-49.
  10. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Journal of Substance Abuse Treatment, 35: 445-450.
  11. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Identifying methamphetamine users at risk for major depressive disorder: findings from the Methamphetamine Treatment Project at 3-year follow-up. American Journal on Addictions, 17: 99-102.
  12. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Risk factors for suicide attempts in methamphetamine dependent patients. American Journal on Addictions, 17(1): 24-27.
  13. Pechnick, R., Glasner-Edwards, S., Wilkins, J. (2007). Preclinical development and clinical implementation of treatments for substance abuse disorders. FOCUS, 5(2): 151-162.  
  14. Glasner-Edwards, S.V., Tate, S.R., McQuaid, J.R., Cummins, K., Granholm, E., & Brown, S.A. (2007). Mechanisms of action in integrated cognitive behavioral treatment versus 12-Step facilitation for substance dependent adults with comorbid major depression. Journal of Studies on Alcohol and Drugs, 68(5): 663-672.
  15. Brown, S.A., Glasner-Edwards, S.V., Tate, S.R., McQuaid, J.R., Chalekian, J., & Granholm, E. (2006). Integrated cognitive behavioral therapy versus twelve-step facilitation for substance dependent adults with depressive disorders. Journal of Psychoactive Drugs, 38(4): 449-460.
  16. Tate, S.R., Brown, S.A., Glasner, S.V., Unrod, M., & McQuaid, J. (2006). Stress and temptation in substance relapse: additive or synergistic effects. Addiction Research & Theory, 14(3): 303-322.